Current and historical daily PE Ratio for Nanexa AB (
) from 2015 to Jun 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Nanexa AB stock (OSTO:NANEXA) PE ratio as of Jun 20 2024 is 0.
More Details
Nanexa AB (OSTO:NANEXA) PE Ratio (TTM) Chart
Nanexa AB (OSTO:NANEXA) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1293
- 1
- 2
- 3
- 4
- 5
- 6
- 15
Nanexa AB PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-20 | At Loss | 2024-04-15 | At Loss |
2024-06-19 | At Loss | 2024-04-12 | At Loss |
2024-06-18 | At Loss | 2024-04-11 | At Loss |
2024-06-17 | At Loss | 2024-04-10 | At Loss |
2024-06-14 | At Loss | 2024-04-09 | At Loss |
2024-06-13 | At Loss | 2024-04-08 | At Loss |
2024-06-12 | At Loss | 2024-04-05 | At Loss |
2024-06-11 | At Loss | 2024-04-04 | At Loss |
2024-06-10 | At Loss | 2024-04-03 | At Loss |
2024-06-07 | At Loss | 2024-04-02 | At Loss |
2024-06-05 | At Loss | 2024-03-28 | At Loss |
2024-06-04 | At Loss | 2024-03-27 | At Loss |
2024-06-03 | At Loss | 2024-03-26 | At Loss |
2024-05-31 | At Loss | 2024-03-25 | At Loss |
2024-05-30 | At Loss | 2024-03-22 | At Loss |
2024-05-29 | At Loss | 2024-03-21 | At Loss |
2024-05-28 | At Loss | 2024-03-20 | At Loss |
2024-05-27 | At Loss | 2024-03-19 | At Loss |
2024-05-24 | At Loss | 2024-03-18 | At Loss |
2024-05-23 | At Loss | 2024-03-15 | At Loss |
2024-05-22 | At Loss | 2024-03-14 | At Loss |
2024-05-21 | At Loss | 2024-03-13 | At Loss |
2024-05-20 | At Loss | 2024-03-12 | At Loss |
2024-05-17 | At Loss | 2024-03-11 | At Loss |
2024-05-16 | At Loss | 2024-03-08 | At Loss |
2024-05-15 | At Loss | 2024-03-07 | At Loss |
2024-05-14 | At Loss | 2024-03-06 | At Loss |
2024-05-13 | At Loss | 2024-03-05 | At Loss |
2024-05-10 | At Loss | 2024-03-04 | At Loss |
2024-05-08 | At Loss | 2024-03-01 | At Loss |
2024-05-07 | At Loss | 2024-02-29 | At Loss |
2024-05-06 | At Loss | 2024-02-28 | At Loss |
2024-05-03 | At Loss | 2024-02-27 | At Loss |
2024-05-02 | At Loss | 2024-02-26 | At Loss |
2024-04-30 | At Loss | 2024-02-23 | At Loss |
2024-04-29 | At Loss | 2024-02-22 | At Loss |
2024-04-26 | At Loss | 2024-02-21 | At Loss |
2024-04-25 | At Loss | 2024-02-20 | At Loss |
2024-04-24 | At Loss | 2024-02-19 | At Loss |
2024-04-23 | At Loss | 2024-02-16 | At Loss |
2024-04-22 | At Loss | 2024-02-15 | At Loss |
2024-04-19 | At Loss | 2024-02-14 | At Loss |
2024-04-18 | At Loss | 2024-02-13 | At Loss |
2024-04-17 | At Loss | 2024-02-12 | At Loss |
2024-04-16 | At Loss | 2024-02-09 | At Loss |
Nanexa AB (OSTO:NANEXA) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Nanexa AB
ISIN : SE0007074166
Compare
Compare
Traded in other countries / regions
NANEXA.Sweden40M.Germany IPO Date
2015-06-17Description
Nanexa AB is a pharmaceutical company developing injectable drug products based on the proprietary drug delivery system PharmaShell - the high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision. The company develops its products and also has collaboration agreements with several pharma companies, among others AstraZeneca. Geographically, the company derives maximum revenue from Nordic countries.